Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, O Grassmann, N Wyttenbach… - … of pharmaceutical and …, 2016 - Elsevier
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics.
W Kirchmeyer, O Grassmann, N Wyttenbach… - … of pharmaceutical and …, 2016 - folia.unifr.ch
English Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics.
W Kirchmeyer, O Grassmann, N Wyttenbach… - … of pharmaceutical and …, 2016 - sonar.ch
English Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, O Grassmann… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics.
W Kirchmeyer, O Grassmann… - Journal of …, 2016 - europepmc.org
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
[PDF][PDF] Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, O Grassmann, N Wyttenbach… - … of Pharmaceutical and …, 2016 - academia.edu
abstract Many pharmaceutical compounds exhibit polymorphism, which may result in
solvent-mediated phase transformations. Since the polymorphic form has an essential …
solvent-mediated phase transformations. Since the polymorphic form has an essential …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, O Grassmann, N Wyttenbach… - … of Pharmaceutical and …, 2016 - infona.pl
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, N Wyttenbach, J Alsenz, M Kuentz… - 2016 - irf.fhnw.ch
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …
Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics
W Kirchmeyer, N Wyttenbach, J Alsenz, M Kuentz… - irf.fhnw.ch
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-
mediated phase transformations. Since the polymorphic form has an essential influence on …
mediated phase transformations. Since the polymorphic form has an essential influence on …